Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard R Riker

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Pharmacotherapy|February 8, 2017
Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature ReviewRichard R Riker, David J Gagnon, Colman Hatton, et al.
Critical Care Medicine|October 1, 2009
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unitJoseph F Dasta, Sandra L Kane-Gill, Michael Pencina, et al.
Critical Care (London, England)|February 23, 2008
Combined didactic and scenario-based education improves the ability of intensive care unit staff to recognize delirium at the bedsideJohn W Devlin, Francois Marquis, Richard R Riker, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19Richard R Riker, Teresa L May, Gilles L Fraser, et al.
Journal of Substance Use and Addiction Treatment|October 1, 2023
Medications for opioid use disorder prescribed at hospital discharge associated with decreased opioid agonist dispensing in patients with opioid use disorder requiring critical care: A retrospective studyAurora Quaye, Chelsea Wampole, Richard R Riker, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndromeRichard R Riker, Teresa L May, Gilles L Fraser, et al.
Critical Care (London, England)|November 16, 2017
Cefepime-induced neurotoxicity: a systematic reviewLauren E Payne, David J Gagnon, Richard R Riker, et al.
Critical Care Explorations|August 4, 2022
Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational StudyChelsea Wampole, Ariel McKenna, Richard R Riker, et al.
Critical Care Medicine|November 17, 2009
Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot studyJohn W Devlin, Russel J Roberts, Jeffrey J Fong, et al.
Journal of Clinical Pharmacology|May 19, 2023
Buprenorphine Continuation During Critical Illness Associated With Decreased Inpatient Opioid Use in Individuals Maintained on Buprenorphine for Opioid Use Disorder in a Retrospective StudyAurora Quaye, Chelsea Wampole, Richard R Riker, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Pharmacotherapy|February 8, 2017
Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature ReviewRichard R Riker, David J Gagnon, Colman Hatton, et al.
Critical Care Medicine|October 1, 2009
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unitJoseph F Dasta, Sandra L Kane-Gill, Michael Pencina, et al.
Critical Care (London, England)|February 23, 2008
Combined didactic and scenario-based education improves the ability of intensive care unit staff to recognize delirium at the bedsideJohn W Devlin, Francois Marquis, Richard R Riker, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19Richard R Riker, Teresa L May, Gilles L Fraser, et al.
Journal of Substance Use and Addiction Treatment|October 1, 2023
Medications for opioid use disorder prescribed at hospital discharge associated with decreased opioid agonist dispensing in patients with opioid use disorder requiring critical care: A retrospective studyAurora Quaye, Chelsea Wampole, Richard R Riker, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndromeRichard R Riker, Teresa L May, Gilles L Fraser, et al.
Critical Care (London, England)|November 16, 2017
Cefepime-induced neurotoxicity: a systematic reviewLauren E Payne, David J Gagnon, Richard R Riker, et al.
Critical Care Explorations|August 4, 2022
Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational StudyChelsea Wampole, Ariel McKenna, Richard R Riker, et al.
Critical Care Medicine|November 17, 2009
Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot studyJohn W Devlin, Russel J Roberts, Jeffrey J Fong, et al.
Journal of Clinical Pharmacology|May 19, 2023
Buprenorphine Continuation During Critical Illness Associated With Decreased Inpatient Opioid Use in Individuals Maintained on Buprenorphine for Opioid Use Disorder in a Retrospective StudyAurora Quaye, Chelsea Wampole, Richard R Riker, et al.
Pageof 13